Transplantation for unresectable perihilar cholangiocarcinoma beyond the Mayo protocol: a challenge for SURE [0.03%]
超越梅奥协议的不可切除的肝门胆管癌移植治疗：SURE面临的挑战
Hendrien Kuipers,Rory L Smoot,Frederik J H Hoogwater
Hendrien Kuipers
Single-port robotic pancreaticoduodenectomy with the SHURUI snake-arm system: first clinical application [0.03%]
带有SHURUI蛇臂系统的单端口机器人胰十二指肠切除术：首次临床应用
Jianjun Leng,Jian Feng,Chenglin Piao et al.
Jianjun Leng et al.
Hepatocellular carcinoma surveillance-is it time to update clinical practice? [0.03%]
肝细胞癌的筛查——是时候更新临床实践了吗？
Jessica Yang,Jacob George
Jessica Yang
Liver dysfunction associated with severe acute pancreatitis: molecular mechanisms and clinical insights [0.03%]
重症急性胰腺炎相关肝功能障碍：分子机制与临床认识
Wumeng Jin,Shuifang Jin
Wumeng Jin
Does neoadjuvant therapy reduce pancreatic fistula after pancreatoduodenectomy and distal pancreatectomy?-a systematic review and meta-analysis [0.03%]
新辅助治疗可以减少胰十二指肠切除术和远端胰腺切除术后胰漏发生吗？-系统评价和meta分析
Sandro Hügli,Victor Lopez-Lopez,Sarvar Abdurakhmonov et al.
Sandro Hügli et al.
Background: Postoperative pancreatic fistula (POPF) is a major complication after pancreatic resection. This systematic review and meta-analysis investigated the impact of neoadjuvant therapy (NAT) on POPF rates after pan...
Refining prognostication in intermediate-stage hepatocellular carcinoma after transarterial chemoembolization: promise and limitations of the proposed NTAA model [0.03%]
经肝动脉化疗栓塞术后中度阶段肝细胞癌预后分层的进一步优化：NTAA模型的前景与局限性
Philipp Schindler,Max Masthoff
Philipp Schindler
Anji Wall,Giuliano Testa
Anji Wall
Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter study [0.03%]
肝癌微血管侵犯的手术后早期复发及门静脉化疗栓塞辅助治疗疗效的预测：多中心研究
Tian-Chen Zhang,Zhen-Qi Li,Wei-Li Jia et al.
Tian-Chen Zhang et al.
Background: Patients with hepatocellular carcinoma (HCC) and microvascular invasion (MVI) are susceptible to early recurrence (ER) after hepatectomy. The use of postoperative adjuvant transcatheter arterial chemoembolizat...
Benchmarking performance in robotic liver resection: are we measuring what matters? [0.03%]
机器人肝脏切除术的性能评估：我们关注的是重要的指标吗？
Francesca Tozzi,Filip Gryspeerdt,Hasan Eker et al.
Francesca Tozzi et al.
Enhanced long-term outcomes with laparoscopic bariatric surgery in patients with severe obesity and metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study [0.03%]
腹腔镜代谢手术治疗肥胖合并代谢功能紊乱相关性肝病的长期疗效观察：回顾性队列研究
Xinrong Zhang,Nicholas Rouillard,Xianhua Mao et al.
Xinrong Zhang et al.
Background: Bariatric surgery is a potential treatment for weight loss in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and severe obesity. However, the impact of bariatric surgery types o...